Outcomes in relation to antithrombotic therapy among patients with atrial fibrillation after percutaneous coronary intervention.

ABSTRACT:

Backgrounds

We investigated the prognostic impact of antithrombotic regimens at 1-year after percutaneous coronary intervention (PCI) among patients with atrial fibrillation (AF).

Method and results

A total of 13,278 AF patients who underwent PCI from 2009 to 2013 were selected from Korean National Health Insurance Service database. Patients were categorized by antithrombotic regimens at 1-year after PCI: (1) OAC with or without single antiplatelet (OAC±SAPT); (2) triple therapy (TT) and (3) antiplatelets (APT) only. After propensity score matching, composite ischaemia (death, myocardial infarction, and stroke), composite bleeding (intracranial hemorrhage and gastrointestinal bleeding), and a composite clinical outcome (composite ischaemia and bleeding) were compared. Of tot

SUBMITTER: Park J 

PROVIDER: S-EPMC7561121 | biostudies-literature | 2020

REPOSITORIES: biostudies-literature